Yeast Instead of Serum

Cultivated meat has an economics problem hiding inside its supply chain. For years the industry relied on fetal bovine serum, a growth-boosting liquid drawn from cattle blood, to keep animal cells dividing in the vat. The field has since moved toward chemically defined media that swap serum for purified growth factors, which resolved the ethics and supply concerns while creating a fresh cost burden: purification alone can consume 40 to 60 percent of what those growth factors cost. A recent filing from the Technical University of Denmark works around that bottleneck using a yeast that already lives in your fridge.

The application (WO2026159118A1) describes engineering Yarrowia lipolytica, a yeast with a long history in food and biotechnology, to produce the growth factors and helper proteins that cultured cells need. The method gains its edge from what the inventors leave out. They grow the yeast, break the cells open, and use the whole lysate (the crude cellular soup) directly in the culture medium, which removes the extraction and purification stages completely. One strain co-expressing four proteins (FGF2, serum albumin, fetuin, and transferrin) supported bovine muscle-cell growth at levels comparable to serum-based medium, and adding as little as 0.5 percent yeast lysate replaced individual purified ingredients in their tests. The lysate also survived freeze-drying and room-temperature storage, which opens a realistic path to shipping and scaling the material.

The Technical University of Denmark, through its Biosustain center, has built a strong reputation for engineering microbes that serve food and sustainability goals. This filing extends that program directly, aiming synthetic biology and microbial-foods research at one of cultivated meat's most stubborn cost barriers. The choice of Yarrowia reflects that food-first thinking, since the species is already established in food production and grows on cheap substrates, which keeps the whole system pointed at affordability rather than pharmaceutical-grade output.

Congratulations and a warm thank you to the inventors: Ridwan Elemosho, Leonie Johanna Jahn, and Morten Otto Alexander Sommer, for work that could make serum-free cultivation genuinely cheap.

I’m Kandice Vincent, a writer and editor covering cellular agriculture, food tech, and the future of how we produce and consume food. I work closely with founders, researchers, and mission-driven companies to turn complex science into something people can actually understand. I care deeply about where food is headed, how we get there, and who’s shaping that future. Based in Mexico, I’m usually writing with my rescue dog Taco nearby, who remains unimpressed by patents but highly invested in mealtimes. Lab Grown Technologies highlights meaningful innovations shaping the future of cellular agriculture and tissue engineering.

Join the conversation and share your thoughts on LinkedIn (linkedin.com/company/lab-grown-technologies/)

This article is based on publicly available information. Lab Grown Technologies is not affiliated with the inventors or organizations mentioned.

We help teams present their technology and make it visible to a highly engaged audience in food and biotech, capturing interest from people and organizations that may benefit from your solution.